• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Excaliard Pharmaceuticals

edit

Excaliard is a newly formed, venture capital-funded biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and other fibrotic diseases.

Milestones

edit

• 
  Excaliard Pharmaceuticals added Niall O'Donnell as Observer.
  Posted 3/24/10 at 7:12am
• 
  Excaliard Pharmaceuticals received $15.5M in Series A funding. (11/27/07)
  Posted 3/12/10 at 11:47pm via excaliard.com

Videos

Screenshots

edit

Above: Excaliard Pharmaceuticals
Uploaded: 3/13/10

Sources

1. Excaliard closes $15.5 million Series A financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners (excaliard.com) [edit]